Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Traumatic Brain Injury

In brief

The purpose of this study is to examine the efficacy of sertraline to prevent the onset of mood and anxiety disorders during the first six months after traumatic brain injury.

Key facts

Study ID
NCT00704379
Run by
Baylor College of Medicine
People needed
94
Starts
2008-06-01
Expected to finish
2014-04-01
Last updated by the study team
2015-08-25

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.